Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-tubulin is one half of the alpha/beta tubulin heterodimer that forms the basic building block of microtubules, which are cylindrical polymers critical for maintaining eukaryotic cell structure, intracellular transport, chromosome segregation during mitosis/meiosis, ciliary/flagellar motility, and other essential cellular processes. Each monomer binds GTP; GTP bound at the E-site on β-subunit can be hydrolyzed after incorporation into the growing microtube filament—a process central to dynamic instability required for normal function. Multiple gene products/isotypes exist with tissue-specific expression patterns; these differences can influence drug sensitivity/resistance profiles. The intermediate domain contains binding sites for important anticancer drugs such as paclitaxel/taxol. Because disruption or stabilization of this system impairs cell division—especially in rapidly proliferating tumor cells—beta-tublin has become a major focus for chemotherapeutic intervention but also presents challenges related to toxicity due its fundamental role across many healthy tissues.
Drugs targeting beta-tubulin generally act by: - Stabilizing microtubules, preventing their depolymerization (e.g., taxanes like paclitaxel), which blocks mitosis and leads to apoptosis in rapidly dividing cells. - Destabilizing microtubules, inhibiting their polymerization or promoting disassembly (e.g., vinca alkaloids like vincristine), also leading to mitotic arrest and cell death.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule network protein beta-tubulin subunit (Beta-tubulin).